ALZcure is pioneering blockchain-powered funding for Alzheimer's research through Decentralized Science (DeSci). Built on ...

"At Aperture, we bring the universe down to Earth and explore the human condition through thought-provoking stories, mind-bending concepts, and groundbreaking discoveries. Follow us for more ...

Alnylam has the FDA approval it sought for Amvuttra in a form of cardiomyopathy associated with rare disease ATTR amyloidosis ...

FY 2024 net revenue of $23.6 million, driven by net revenue of $12.0 million during fourth quarter of 2024Entered into asset purchase agreement ...

INmune Bio's high-upside potential with CORDStrom for RDEB and XPro for Alzheimer's, offering up to 144.8x returns. Click ...

FY 2024 net revenue of $23.6 million, driven by net revenue of $12.0 million during fourth quarter of 2024 Entered into asset purchase agreement for sale of PRV for $150 million Company to host confer ...

Some cars had the looks, handling, and appeal but were let down by bad engines. Whether unreliable or underpowered, they fell ...

That which separates poor Lazarus from the rich man is not so much the door of the latter’s grand house but his indifference to and low regard of the beggar. He sees himself as master who looks at ...

Speaking with GEN Edge recently, Guilliams said HLX-1502 offers nerve-specific accumulation resulting in a half-life of 90 hours ... priority review voucher (PRV). A 2024 study pegged the average ...

I know it's part of getting older, but when my husband was told to go to the ER because a clinical trial EKG had revealed an irregular heartbeat, I was startled almost into one of my own.

Get the latest Thailand & SEA video news: crime, pollution, real estate boom, MH370 search, & more in today's update.